Think Big,
Think Microsize!
Micronization at its Finest
For over 30 years, Microsize has been a pioneer in enhancing dissolution and bioavailability of Active Pharmaceutical Ingredients (APIs) via particle size reduction using micronization technologies.
APIs Processed
Production Campaigns
Largest US Micronization Footprint
Years of Experience
Years of Successful FDA Inspections
Countless – Satisfied Customers
Contract Services
Particle Size Reduction:
Micronization & milling
Particle Classification:
Multiple screening technologies
Analytical Characterization:
Laser diffraction and morphology techniques
The Microsize Advantage
Decades of Experience
Hundreds of APIs processed in thousands of campaigns
Unparalleled Depth of Expertise
Pioneers in micronization technology
Largest US-based Footprint
Three facilities, >100,000 sqft, FDA inspected
World Class Containment Technologies
Hard wall and single use technologies for HPAPI
High Touch, Low Bureaucracy
Focused on relationship and speed
Enhanced Bioavailability: Accelerated
First-Choice Technology
Fastest approach to improving bioavailability and solubility
Streamlined Regulatory Pathway
Low regulatory risk; Implemented in numerous IND and NDA filings
Readily Scalable
Proven from grams to tons; limited variables of scale enhances speed
High Yielding
High throughput with minimal losses means competitive costing
Superb Precision/ Reproducibility
Narrow Gaussian PSD curves enhances quality and performance